Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Glioblastoma, IDH-Wildtype”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Not applicableStudy completedNCT05759195
What this trial is testing

Biomolecular Analysis for Predicting Response to Regorafenib

Who this might be right for
GlioblastomaGlioblastoma, IDH-wildtype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 53
Testing effectiveness (Phase 2)Study completedNCT00179907
What this trial is testing

A Phase I/II Study of the Photon Radiosurgery System

Who this might be right for
Brain Tumor, RecurrentGlioblastoma Multiforme
Ann & Robert H Lurie Children's Hospital of Chicago 35
Very early researchEnrolling By InvitationNCT07520214
What this trial is testing

Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeGlioblastom WHO Grade 4
Beijing Neurosurgical Institute 9
Very early researchLooking for participantsNCT06552260
What this trial is testing

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Ugonma Chukwueke 27
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Not applicableLooking for participantsNCT06283927
What this trial is testing

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen 464
Not applicableLooking for participantsNCT06430424
What this trial is testing

Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

Who this might be right for
Relapsed CancerGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
University Hospital, Bordeaux 40
Very early researchActive Not RecruitingNCT06824662
What this trial is testing

Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas

Who this might be right for
Glioblastoma WHO Grade IV
Nader Sanai 30
Early research (Phase 1)Active Not RecruitingNCT06410248
What this trial is testing

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-WildtypeRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more
Northwestern University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07349693
What this trial is testing

Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
Everfront Biotech Co., Ltd. 175
Early research (Phase 1)Active Not RecruitingNCT05236036
What this trial is testing

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Who this might be right for
AstrocytomaGlioblastomaGlioblastoma, IDH-Wildtype+2 more
Northwestern University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05465954
What this trial is testing

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Who this might be right for
High Grade Astrocytic TumorRecurrent Glioblastoma, IDH-WildtypeRecurrent Gliosarcoma
Mayo Clinic 54
Early research (Phase 1)Not Yet RecruitingNCT07385846
What this trial is testing

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

Who this might be right for
GlioblastomaMismatch Repair Deficiency
Jennifer Leddon 8
Early research (Phase 1)Looking for participantsNCT06455605
What this trial is testing

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Who this might be right for
Recurrent Glioblastoma IDH Wildtype
Darell Bigner 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07386002
What this trial is testing

The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
T-MAXIMUM Pharmaceutical Inc 40
Testing effectiveness (Phase 2)Looking for participantsNCT05765812
What this trial is testing

Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
Debiopharm International SA 116
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
IDH Wildtype GlioblastomaRecurrent AstrocytomaIDH Wildtype Recurrent Glioblastoma+2 more
Jonsson Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07416188
What this trial is testing

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more
National Institute of Neurological Disorders and Stroke (NINDS) 40
Early research (Phase 1)Looking for participantsNCT05789394
What this trial is testing

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Who this might be right for
Recurrent Glioblastoma, IDH-WildtypeRecurrent Astrocytoma, IDH-Mutant, Grade 4Astrocytoma, Grade IV
Mayo Clinic 20
Load More Results